KEGG MEDICUS 医薬品情報

利用法   Top
2545 件中 1 〜 40 を表示 1 2 3 4 5 6 ... 64 次へ
エントリ 名称 カテゴリ パスウェイ 病因遺伝子
H00001 B細胞急性リンパ性白血病
B細胞リンパ芽球性白血病
がん BCR-ABL (translocation) [HSA:25] [KO:K06619]
MLL-AF4 (translocation) [HSA:4297 4299] [KO:K09186 K15184]
E2A-PBX1 (translocation) [HSA:6929 5087] [KO:K09063 K09355]
TEL-AML1 (translocation) [HSA:861] [KO:K08367]
c-MYC (rearrangement) [HSA:4609] [KO:K04377]
CRLF2 (rearrangement) [HSA:64109] [KO:K05078]
PAX5 (rearrangement) [HSA:5079] [KO:K09383]
H00002 T細胞急性リンパ性白血病
T細胞リンパ芽球性白血病
がん NOTCH1 (mutation) [HSA:4851] [KO:K02599]
TAL1 (overexpression) [HSA:6886] [KO:K09068]
TAL2 [HSA:6887] [KO:K09068]
LYL1 (expression) [HSA:4066] [KO:K15604]
MLL-ENL (translocation) [HSA:4297] [KO:K09186]
HOX11 (translocation) [HSA:3195] [KO:K09340]
MYC (translocation) [HSA:4609] [KO:K04377]
LMO2 (translocation) [HSA:4005] [KO:K15612]
HOX11L2 (translocation) [HSA:30012] [KO:K15607]
PICALM-MLLT10 (translocation) [HSA:8028] [KO:K23588]
H00003 急性骨髄性白血病 がん hsa05221 急性骨髄性白血病 FLT3 (mutation) [HSA:2322] [KO:K05092]
c-KIT (mutation) [HSA:3815] [KO:K05091]
N-ras (mutation) [HSA:4893] [KO:K07828]
K-ras (mutation) [HSA:3845] [KO:K07827]
PML-RARalpha (translocation) [HSA:5371] [KO:K10054]
AML1-ETO (translocation) [HSA:861] [KO:K08367]
PLZF-RARalpha (translocation) [HSA:7704] [KO:K10055]
AML1 (mutation) [HSA:861] [KO:K08367]
C/EBPalpha (mutation) [HSA:1050] [KO:K09055]
PU.1 (mutation) [HSA:6688] [KO:K09438]
CBFB [HSA:865]
CHIC2 [HSA:26511]
DNMT3A (mutation) [HSA:1788] [KO:K17398]
ETV6 (germline mutation) [HSA:2120] [KO:K03211]
GATA2 (mutation) [HSA:2624] [KO:K17894]
JAK2 (mutation) [HSA:3717] [KO:K04447]
LPP [HSA:4026] [KO:K16676]
MLLT10 [HSA:8028] [KO:K23588]
NPM1 (mutation) [HSA:4869] [KO:K11276]
NUP214 [HSA:8021] [KO:K14317]
PICALM [HSA:8301] [KO:K20044]
SH3GL1 [HSA:6455] [KO:K11247]
TERT (mutation) [HSA:7015] [KO:K11126]
H00004 慢性骨髄性白血病 がん hsa05220 慢性骨髄性白血病 BCR-ABL (translocation) [HSA:613 25] [KO:K08878 K06619]
EVI1 (overexpression) [HSA:2122] [KO:K04462]
AML1 (translocation) [HSA:861] [KO:K08367]
p16/INK4A (mutation) [HSA:1029] [KO:K06621]
p53 (mutation) [HSA:7157] [KO:K04451]
RB1 (mutation) [HSA:5925] [KO:K06618]
H00005 慢性リンパ性白血病 がん Bcl-2 (overexpression) [HSA:596] [KO:K02161]
p53 (mutation) [HSA:7157] [KO:K04451]
ATM (germline and somatic mutation) [HSA:472] [KO:K04728]
Fas (absent) [HSA:355] [KO:K04390]
H00006 有毛細胞白血病
ヘアリー細胞白血病
ヘアリーセル白血病
がん p53 (mutation) [HSA:7157] [KO:K04451]
Bcl-6 (mutation) [HSA:604] [KO:K15618]
Cyclin D1 (overexpression) [HSA:595] [KO:K04503]
H00007 ホジキンリンパ腫 がん IKBA (mutation) [HSA:4792] [KO:K04734]
IKBE (mutation) [HSA:4794] [KO:K05872]
c-rel (amplification) [HSA:5966] [KO:K09254]
CD95 (mutation) [HSA:355] [KO:K04390]
KLHDC8B [HSA:200942]
H00008 バーキットリンパ腫 がん MYC-IgH (translocation) [HSA:4609] [KO:K04377]
p53 (mutation) [HSA:7157] [KO:K04451]
p16/INK4A (promoter methylation) [HSA:1029] [KO:K06621]
H00009 成人T細胞性白血病 がん hsa05166 ヒトT細胞白血病ウイルス1感染 p53 (mutation) [HSA:7157] [KO:K04451]
p16/INK4A (deletion, promoter methylation) [HSA:1029] [KO:K06621]
Fas (mutation) [HSA:355] [KO:K04390]
H00010 多発性骨髄腫 がん CCND1-IgH (translocation) [HSA:595] [KO:K04503]
CCND3-IgH (translocation) [HSA:896] [KO:K10152]
IgH-FGFR3 (translocation) [HSA:2261] [KO:K05094]
IgH-MMSET (translocation) [HSA:7468] [KO:K11424]
IgH-MAF (translocation) [HSA:4094] [KO:K09035]
N-ras (activating mutation) [HSA:4893] [KO:K07828]
K-ras (activating mutation) [HSA:3845] [KO:K07827]
c-MYC (dysregulation) [HSA:4609] [KO:K04377]
p53 (mutation) [HSA:7157] [KO:K04451]
H00011 リンパ形質細胞性リンパ腫 がん Pax5-IgH (translocation) [HSA:5079] [KO:K09383]
H00012 真性赤血球増加症 がん JAK2 (mutation) [HSA:3717] [KO:K04447]
H00013 小細胞肺癌 がん hsa05222 小細胞肺癌 c-MYC (amplification) [HSA:4609] [KO:K04377]
RAR-beta (promoter hypermethylation) [HSA:5915] [KO:K08528]
FHIT (mutation) [HSA:2272] [KO:K01522]
p53 (LOH, mutation) [HSA:7157] [KO:K04451]
RB1 (LOH, mutation) [HSA:5925] [KO:K06618]
PTEN (mutation, deletion) [HSA:5728] [KO:K01110]
Bcl-2 (overexpression) [HSA:596] [KO:K02161]
PPP2R1B(deletion) [HSA:5519] [KO:K03456]
H00014 非小細胞肺癌 がん hsa05223 非小細胞肺癌 K-ras (mutation) [HSA:3845] [KO:K07827]
EGFR (mutation) [HSA:1956] [KO:K04361]
RAR-beta (promoter hypermethylation) [HSA:5915] [KO:K08528]
FHIT (mutation) [HSA:2272] [KO:K01522]
RASSF1 (promoter hypermethylation) [HSA:11186] [KO:K09850]
p16/INK4A (mutation) [HSA:1029] [KO:K06621]
p53 (mutation/deletion) [HSA:7157] [KO:K04451]
EML4-ALK (translocation) [HSA:238] [KO:K05119]
KIF5B-RET (inversion) [HSA:5979] [KO:K05126]
CD74-ROS1,SLC34A2-ROS1 (translocation) [HSA:6098] [KO:K05088]
MET (mutation) [HSA:4233] [KO:K05099]
BRAF (mutation) [HSA:673] [KO:K04365]
PIK3CA (mutation) [HSA:5290] [KO:K00922]
IRF1(mutation) [HSA:3659] [KO:K09444]
PPP2R1B(mutation, deletion) [HSA:5519] [KO:K03456]
H00015 悪性胸膜中皮腫 がん p53 (inactivation) [HSA:7157] [KO:K04451]
p16/CDKN2A (deletion) [HSA:1029] [KO:K06621]
p15/CDKN2B (deletion) [HSA:1030] [KO:K04685]
NF2 (mutation) [HSA:4771] [KO:K16684]
PDGF-A (overexpression) [HSA:5154] [KO:K04359]
PDGF-B (overexpression) [HSA:5155] [KO:K17386]
IGF-1 (expression) [HSA:3479] [KO:K05459]
IGF-R1 (expression) [HSA:3480] [KO:K05087]
H00016 口腔癌 がん p53 (mutation, deletion) [HSA:7157] [KO:K04451]
p16/INK4A (mutation, loss of expression) [HSA:1029] [KO:K06621]
EGFR (overexpression) [HSA:1956] [KO:K04361]
c-myc/N-myc (amplification, overexpression) [HSA:4609] [KO:K04377]
N-ras (amplification) [HSA:4893] [KO:K07828]
K-ras (amplification) [HSA:3845] [KO:K07827]
Cyclin D1 (amplification) [HSA:595] [KO:K04503]
STAT-3 (expression) [HSA:6774] [KO:K04692]
H00017 食道癌 がん EGFR (overexpression) [HSA:1956] [KO:K04361]
p53 (mutation) [HSA:7157] [KO:K04451]
p16/INK4A (homozygous deletion, LOH) [HSA:1029] [KO:K06621]
RB1 (LOH) [HSA:5925] [KO:K06618]
iNOS (increased expression) [HSA:4843] [KO:K13241]
COX2 (overexpression) [HSA:5743] [KO:K11987]
APC (LOH) [HSA:324] [KO:K02085]
Cyclin D1 (amplification) [HSA:595] [KO:K04503]
FAS (increased expression) [HSA:355] [KO:K04390]
DCC [HSA:1630] [KO:K06765]
LZTS1 [HSA:11178]
RNF6 [HSA:6049] [KO:K22753]
TGFBR2 [HSA:7048] [KO:K04388]
WWOX [HSA:51741] [KO:K19329]
H00018 胃癌 がん hsa05226 胃癌 CDX2 (overexpression) [HSA:1045] [KO:K22234]
p53 (mutation) [HSA:7157] [KO:K04451]
RARB (reduced expression) [HSA:5915] [KO:K08528]
APC (mutation) [HSA:324] [KO:K02085]
CTNNB1 (mutation) [HSA:1499] [KO:K02105]
TERT (overexpression) [HSA:7015] [KO:K11126]
ERBB2 (amplification) [HSA:2064] [KO:K05083]
KRAS (mutation) [HSA:3845] [KO:K07827]
NRAS (mutation) [HSA:4893] [KO:K07828]
MLH1 (methylation) [HSA:4292] [KO:K08734]
CDKN1B (reduced expression) [HSA:1027] [KO:K06624]
CCNE1 (amplification) [HSA:898] [KO:K06626]
TGFBR1 (reduced expression) [HSA:7046] [KO:K04674]
CDH1 (mutation) [HSA:999] [KO:K05689]
MET (amplification) [HSA:4233] [KO:K05099]
FGFR2 (amplification) [HSA:2263] [KO:K05093]
MUTYH [HSA:4595] [KO:K03575]
PIK3CA [HSA:5290] [KO:K00922]
H00019 膵癌 がん hsa05212 膵癌 K-ras (mutation) [HSA:3845] [KO:K07827]
ERBB2 (overexpression) [HSA:2064] [KO:K05083]
p16/INK4A (mutation, deletion, promoter methylation) [HSA:1029] [KO:K06621]
p53 (mutation) [HSA:7157] [KO:K04451]
SMAD4 (mutation) [HSA:4089] [KO:K04501]
STK11 (germline mutation) [HSA:6794] [KO:K07298]
(PNCA1) PALLD [HSA:23022] [KO:K22029]
(PNCA2) BRCA2 (germline mutation) [HSA:675] [KO:K08775]
(PNCA3) PALB2 [HSA:79728] [KO:K10897]
(PNCA4) BRCA1 [HSA:672] [KO:K10605]
(PNCA5) RABL3 [HSA:285282] [KO:K07933]
H00020 結腸・直腸癌
大腸癌
がん hsa05210 大腸癌 beta-Catenin (mutation) [HSA:1499] [KO:K02105]
K-ras (mutation) [HSA:3845] [KO:K07827]
APC (germline mutation (FAP), somatic mutation) [HSA:10297] [KO:K02085]
DCC (deletion) [HSA:1630] [KO:K06765]
TGF-betaRII (mutation) [HSA:7048] [KO:K04388]
Smad2 (mutation) [HSA:4087] [KO:K04500]
Smad4 (deletion) [HSA:4089] [KO:K04501]
BAX (mutation) [HSA:581] [KO:K02159]
p53 (deletion) [HSA:7157] [KO:K04451]
MLH1 (germline mutation (HNPCC), LOH, promoter hypermethylation) [HSA:4292] [KO:K08734]
MSH2 (germline mutation (HNPCC), LOH, somatic mutation) [HSA:4436] [KO:K08735]
MSH3 (somatic frameshift mutation) [HSA:4437] [KO:K08736]
MSH6 (germline mutation (HNPCC), LOH, somatic frameshift mutation) [HSA:2956] [KO:K08737]
GALNT12 (germline mutation, somatic mutation) [HSA:79695] [KO:K00710]
EGF (overexpression) [HSA:1950] [KO:K04357]
TGFA (overexpression) [HSA:7039] [KO:K08774]
EREG (overexpression) [HSA:2069] [KO:K09784]
AREG (overexpression) [HSA:374] [KO:K09782]
AXIN2 [HSA:8313] [KO:K04385]
BRAF [HSA:637] [KO:K04726]
CCND1 [HSA:595] [KO:K04503]
CHEK2 [HSA:11200] [KO:K06641]
FLCN [HSA:201163] [KO:K09594]
MLH3 [HSA:27030] [KO:K08739]
PIK3CA [HSA:5290] [KO:K00922]
H00021 腎細胞癌 がん hsa05211 腎細胞癌 VHL (germline mutation (VHL disease), somatic mutation) [HSA:7428] [KO:K03871]
Met (germline activating mutation (HPRC), somatic activating mutation) [HSA:4233] [KO:K05099]
FH (germline loss-of-function mutation (HLPCC), LOH, somatic mutation) [HSA:2271] [KO:K01679]
BHD (germline mutation (Birt-Hogg-Dube syndrome)) [HSA:201163] [KO:K09594]
PRCC-TFE3 (translocation) [HSA:7030] [KO:K09105]
HNF1A [HSA:6927] [KO:K08036]
OGG1 [HSA:4968] [KO:K03660]
PBRM1 [HSA:55193] [KO:K11757]
PRCC [HSA:5546] [KO:K13105] [KO;K13105]
H00022 膀胱癌 がん hsa05219 膀胱癌 H-ras (activating mutation) [HSA:3265] [KO:K02833]
FGFR3 (activating mutation) [HSA:2261] [KO:K05094]
p16/INK4A (homozygous deletion or hypermethylation) [HSA:1029] [KO:K06621]
p53 (inactivating mutation or deletion) [HSA:7157] [KO:K04451]
RB1 (deletion or hyperphosphorylation) [HSA:5925] [KO:K06618]
EGFR (overexpression) [HSA:1956] [KO:K04361]
ERBB2 (overexpression) [HSA:2064] [KO:K05083]
RASSF1 (hypermethylation) [HSA:11186] [KO:K09850]
DAPK1 (hypermethylation) [HSA:1612] [KO:K08803]
H00023 精巣癌 がん CCND2 (amplification) [HSA:894] [KO:K10151]
FGFR3 [HSA:2261] [KO:K05094]
KIT [HSA:3815] [KO:K05091]
STK11 [HSA:6794] [KO:K07298]
H00024 前立腺癌 がん hsa05215 前立腺癌 AR (amplification, mutation) [HSA:367] [KO:K08557]
CDKN1B (allelic loss) [HSA:1027] [KO:K06624]
NKX3.1 (allelic loss) (decreased expression) [HSA:4824] [KO:K09348]
PTEN (allelic loss) [HSA:5728] [KO:K01110]
GSTP1 (hypermethylation) [HSA:2950] [KO:K23790]
TMPRSS2-ERG (translocation) [HSA:2078] [KO:K09435]
TMPRSS2-ETV1 (translocation) [HSA:2115] [KO:K09431]
TMPRSS2-ETV4 (translocation) [HSA:2118] [KO:K15592]
TMPRSS2-ETV5 (translocation) [HSA:2119] [KO:K15593]
SLC45A3-ETV1 (translocation) [HSA:2115] [KO:K09431]
SLC45A3-ELK4 (translocation) [HSA:2005] [KO:K04376]
DDX5-ETV4 (translocation) [HSA:2118] [KO:K15592]
MAD1L1 (somatic mutation) [HSA:8379] [KO:K06679]
KLF6 (somatic mutation) [HSA:1316] [KO:K09207]
MXI1 (somatic mutation) [HSA:4601] [KO:K09114]
ZFHX3 (somatic mutation) [HSA:463] [KO:K09378]
H00025 陰茎癌 がん p16/INK4a (promoter hypermethylation) [HSA:1029] [KO:K06621]
BMI1 (overexpression) [HSA:648] [KO:K11459]
p53 (mutation) [HSA:7157] [KO:K04451]
MDM2 (overexpression) [HSA:4193] [KO:K06643]
H-ras (mutation) [HSA:3265] [KO:K02833]
c-MYC (mutation) [HSA:4609] [KO:K04377]
E-Cadherin (expression) [HSA:999] [KO:K05689]
MMP-2 (expression) [HSA:4313] [KO:K01398]
MMP-9 (expression) [HSA:4318] [KO:K01403]
COX-2 (expression) [HSA:5743] [KO:K11987]
PTGES2 (expression) [HSA:80142] [KO:K05309]
H00026 子宮内膜癌 がん hsa05213 子宮内膜癌 K-ras (mutational activation) [HSA:3845] [KO:K07827]
beta-Catenin (mutation) [HSA:1499] [KO:K02105]
ERBB2 (amplification) [HSA:2064] [KO:K05083]
PTEN (mutation, deletions, methylation) [HSA:5728] [KO:K01110]
p53 (mutation) [HSA:7157] [KO:K04451]
MLH1 (mutation, methylation) [HSA:4292] [KO:K08734]
MSH3 [HSA:4437] [KO:K08736]
CDH1 [HSA:999] [KO:K05689]
H00027 卵巣癌 がん BRCA1 (germline mutation / deletion) [HSA:672] [KO:K10605]
BRCA2 (germline mutation / deletion) [HSA:675] [KO:K08775]
MSH2 (germline mutation) [HSA:4436] [KO:K08735]
MLH1 (germline mutation) [HSA:4292] [KO:K08734]
ERBB2 (amplification / overexpression) [HSA:2064] [KO:K05083]
K-ras (mutation) [HSA:3845] [KO:K07827]
AKT2 (amplification) [HSA:208] [KO:K04456]
PIK3CA (amplification) [HSA:5290] [KO:K00922]
c-MYC (overexpression) [HSA:4609] [KO:K04377]
p53 (mutation / deletion, overexpression) [HSA:7157] [KO:K04451]
CTNNB1 [HSA:1499] [KO:K02105]
PRKN [HSA:5071] [KO:K04556]
OPCML [HSA:4978] [KO:K06773]
AKT1 [HSA:207] [KO:K04456]
CDH1 [HSA:999] [KO:K05689]
H00028 絨毛癌 がん p53 (overexpression) [HSA:7157] [KO:K04451]
MdM2 (overexpression) [HSA:4193] [KO:K06643]
EGFR (overexpression) [HSA:1956] [KO:K04361]
c-MYC (overexpression) [HSA:4609] [KO:K04377]
ERBB2 (overexpression) [HSA:2064] [KO:K05083]
c-FMS (overexpression) [HSA:1436] [KO:K05090]
Bcl-2 (overexpression) [HSA:596] [KO:K02161]
MMP-1 (overexpression) [HSA:4312] [KO:K01388]
MMP-2 (overexpression) [HSA:4313] [KO:K01398]
H00029 外陰癌 がん PTEN (mutation) [HSA:5728] [KO:K01110]
p53 (mutation) [HSA:7157] [KO:K04451]
H00030 子宮頸癌 がん K-ras (mutation) [HSA:3845] [KO:K07827]
H-ras (mutation) [HSA:3265] [KO:K02833]
EGFR (amplification) [HSA:1956] [KO:K04361]
ERBB2 (amplification) [HSA:2064] [KO:K05083]
p21 (overexpression) [HSA:1026] [KO:K06625]
CDK4 (overexpression) [HSA:1019] [KO:K02089]
Bcl-2 (overexpression) [HSA:596] [KO:K02161]
H00031 乳癌 がん hsa05224 乳癌 BRCA1 (germline mutation, hypermethylation) [HSA:672] [KO:K10605]
BRCA2 [HSA:675] [KO:K08775]
BARD1 [HSA:580] [KO:K10683]
BRIP1 [HSA:83990] [KO:K15362]
PALB2 [HSA:79728] [KO:K10897]
RAD51 [HSA:5888] [KO:K04482]
RAD54L [HSA:8438] [KO:K10875]
HMMR [HSA:3161] [KO:K06267]
NQO2 [HSA:4835] [KO:K08071]
PPM1D [HSA:8493] [KO:K10147]
RB1CC1 [HSA:9821] [KO:K17589]
SLC22A18 [HSA:5002] [KO:K08214]
ESR1 (positive) [HSA:2099] [KO:K08550]
FGFR1 (amplification) [HSA:2260] [KO:K04362]
PIK3CA (mutation) [HSA:5290] [KO:K00922]
PTEN (mutation) [HSA:5728] [KO:K01110]
p53 (mutation) [HSA:7157] [KO:K04451]
CCND1 (amplification) [HSA:595] [KO:K04503]
ERBB2 (overexpression) [HSA:2064] [KO:K05083]
EGFR (overexpression) [HSA:1956] [KO:K04361]
KIT (overexpression) [HSA:3815] [KO:K05091]
Notch1 (overexpression) [HSA:4851] [KO:K02599]
Notch4 (overexpression) [HSA:4855] [KO:K20996]
FZD7 (overexpression) [HSA:8324] [KO:K02432]
LRP6 (overexpression) [HSA:4040] [KO:K03068]
H00032 甲状腺癌 がん hsa05216 甲状腺癌 RET/PTC1 (rearrangement) [HSA:5979 8030] [KO:K05126 K09288]
RET/PTC3 (rearrangement) [HSA:5979 8031] [KO:K05126 K09289]
TPM3/NTRK1 (rearrangement) [HSA:4914 7170] [KO:K03176 K09290]
TPR/NTRK1 (rearrangement) [HSA:7175 7170] [KO:K09291 K09290]
TFG/NTRK1 (rearrangement) [HSA:10342 7170] [KO:K09292 K09290]
H-ras (mutation) [HSA:3265] [KO:K02833]
K-ras (mutation) [HSA:3845] [KO:K07827]
N-ras (mutation) [HSA:4893] [KO:K07828]
BRAF (mutation) [HSA:673] [KO:K04365]
PAX8/PPARgamma (rearrangement) [HSA:7849 5468] [KO:K09293 K08530]
beta-Catenin (mutation) [HSA:1499] [KO:K02105]
p53 (mutation) [HSA:7157] [KO:K04451]
E-cadherin (downregulation) [HSA:999] [KO:K05689]
RET (mutation) [HSA:5979] [KO:K05126]
H00033 副腎癌 がん ACTH-R (deletion) [HSA:4158] [KO:K04200]
GNAI2 (mutation) [HSA:2771] [KO:K04630]
N-ras (mutation) [HSA:4893] [KO:K07828]
IGF II (overexpression) [HSA:3481] [KO:K13769]
p53 (LOH, mutation) [HSA:7157] [KO:K04451]
p16/INK4A (LOH, low expression) [HSA:1028] [KO:K09993]
MEN1 (LOH, mutation) [HSA:4221] [KO:K14970]
H00034 カルチノイド がん MEN1 (mutation, LOH) [HSA:4221] [KO:K14970]
SDHD (germline mutation, LOH) [HSA:6392] [KO:K00237]
H00035 ユーイング肉腫 がん EWSR1-FLI1 (translocation) [HSA:2313] [KO:K09436]
EWSR1-ERG (translocation) [HSA:2078] [KO:K09435]
EWSR1-ETV1 (translocation) [HSA:2115] [KO:K09431]
EWSR1-ETV4 (translocation) [HSA:2118] [KO:K15592]
EWSR1-FEV (translocation) [HSA:54738] [KO:K09437]
H00036 骨肉腫 がん MDM2 (amplification) [HSA:4193] [KO:K06643]
SAS (amplification) [HSA:6302] [KO:K17356]
p53 (losses, rearrangements, point mutation) [HSA:7157] [KO:K04451]
RB1 (losses, rearrangements, point mutation) [HSA:5925] [KO:K06618]
p16/INK4A (mutation) [HSA:1029] [KO:K06621]
CDKN2B (mutation) [HSA:1030] [KO:K04685]
c-MYC (amplification) [HSA:4609] [KO:K04377]
CHEK2 [HSA:11200] [KO:K06641]
H00037 横紋筋肉腫 がん PAX3-FOXO1A (translocation) [HSA:2308] [KO:K07201]
PAX7-FOXO1A (translocation) [HSA:2308] [KO:K07201]
MDM2 (amplification) [HSA:4193] [KO:K06643]
ATR (amplification) [HSA:545] [KO:K06640]
SLC22A18 [HSA:5002] [KO:K08214]
DICER1 [HSA:23405] [KO:K11592]
H00038 悪性黒色腫 がん hsa05218 悪性黒色腫 BRAF (mutation) [HSA:673] [KO:K04365]
NRAS (mutation) [HSA:4893] [KO:K07828]
CDK4 (mutation) [HSA:1019] [KO:K02089]
MITF (amplification) [HSA:4286] [KO:K09455]
PTEN (deletion, germline mutation, somatic mutation, LOH) [HSA:5728] [KO:K01110]
p16/INK4A (loss/mutation) [HSA:1029] [KO:K06621]
p53 (loss/mutation) [HSA:7157] [KO:K04451]
POT1 [HSA:25913] [KO:K11109]
MC1R [HSA:4157] [KO:K04199]
XRCC3 [HSA:7517] [KO:K10880]
TERT [HSA:7015] [KO:K11126]
STK11 [HSA:6794] [KO:K07298]
H00039 基底細胞癌 がん hsa05217 基底細胞癌 SHH (germline, somatic mutation) [HSA:6469] [KO:K11988]
SMO (somatic mutation) [HSA:6608] [KO:K06226]
p53 (mutation) [HSA:7157] [KO:K04451]
PTCH (germline, somatic mutation) [HSA:5727] [KO:K06225]
H00040 有棘細胞癌
扁平上皮癌
がん p53 (mutation) [HSA:7157] [KO:K04451]
p16/INK4A (mutation) [HSA:1029] [KO:K06621]
H-ras (mutation) [HSA:3265] [KO:K02833]
K-ras (mutation) [HSA:3845] [KO:K07827]
2545 件中 1 〜 40 を表示 1 2 3 4 5 6 ... 64 次へ

[ KEGG | KEGG DRUG | KEGG MEDICUS ]